NCT01561833 A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients Status COMPLETED Phase PHASE1
NCT01539018 Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE Status TERMINATED Phase PHASE2
NCT01518413 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01510756 Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL) Status TERMINATED Phase PHASE2
NCT01507064 Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01498952 MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC. Status COMPLETED Phase PHASE1
NCT01482442 SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT01480817 Sorafenib VS TACE in HCC Patients With Portal Vein Invasion Status TERMINATED Phase PHASE2
NCT01444807 Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases Status UNKNOWN Phase PHASE2
NCT01434602 Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas Status COMPLETED Phase PHASE1/PHASE2
NCT01409499 Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE4
NCT01405573 Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma Status TERMINATED Phase PHASE3
NCT01398501 Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant Status COMPLETED Phase PHASE1
NCT01377025 A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma Status UNKNOWN Phase PHASE2
NCT01376453 Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE1
NCT01357486 Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis Status COMPLETED Phase PHASE2
NCT01348503 Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma Status TERMINATED Phase PHASE1
NCT01342627 Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma Status TERMINATED Phase PHASE2
NCT01308723 A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE1